For the first time in years, the national overdose story contains real good news. Provisional CDC data estimate 69,973 Americans died from drug overdoses in 2025, down nearly 14% from 81,313 in 2024 and the third consecutive annual decline. Every one of those numbers is a person who did not become a statistic and a family spared the call that changes everything.

That progress deserves to be celebrated. But as International Overdose Awareness Day arrives on August 31, treatment operators should be careful about the conclusion they draw. Fewer overdose deaths do not mean the crisis is over. They mean the next lives to save are increasingly the ones already inside the treatment system — and the moments where they are lost are operational, not just clinical.

Overdose prevention starts long before the overdose

Much of the national prevention strategy has focused, understandably, on the moment of greatest danger: naloxone access, recognizing an overdose, responding fast. That work must continue. But CDC data show that 67.5% of overdose deaths reported by 43 jurisdictions in 2024 had at least one potential opportunity for intervention before the fatal event.

For a treatment program, those opportunities have recognizable faces. The patient who wants to leave residential on day six. The frightened parent who gets the “come get me, I don’t belong here” call. The family that does not understand why stepping down to PHP or IOP matters. The patient who completes residential and never connects with the next level of care.

Each of those is a transition. Each transition is a point where recovery is strengthened or someone is lost from care. And the data on what happens next is stark.

The first two weeks after treatment ends are the most dangerous

A New York City cohort study of 51,171 patients whose substance use treatment was terminated found 342 overdose deaths within 90 days. Of those, 140 — more than 40% — occurred within the first 14 days. The overdose death rate in that two-week window was 71.6 per 1,000 person-years, nearly three times the already-elevated 90-day rate.

Two findings in that study should get every residential operator’s attention. Patients terminated from residential treatment were significantly more likely to die of overdose than those leaving detox, opioid treatment programs, or outpatient care. And the authors’ recommended response was not more naloxone alone. It was to improve retention, reassess termination criteria, and ensure patients stay connected to ongoing treatment.

SAMHSA’s quality measures reinforce the same concern by tracking whether someone leaving inpatient or residential SUD treatment connects with another treatment service within 7 or 14 days. The window is that narrow.

Getting someone through the front door of treatment can save a life. Keeping them engaged and moving through the continuum of care can save it again.

These are not separate problems

Programs tend to manage overdose prevention, AMA discharge, treatment completion, step-down transitions, family engagement, and post-discharge outcomes as separate workstreams owned by different people. They are not separate. They are consecutive points on the same journey, and a failure at any one of them lands in the same 14-day window the NYC data describes.

Seen that way, the operational metrics most programs already track — AMA rate, completion rate, step-down connection rate — are overdose prevention metrics. A program that reduces early exits is not only protecting census. It is keeping patients out of the highest-risk period there is.

Families can unintentionally raise the risk

Families are often the deciding voice when a patient wants to leave early. Out of fear, guilt, or a desire to relieve their loved one’s distress, they agree to pick them up or support an early discharge. They believe they are rescuing someone. In the data above, they may be moving that person into the most dangerous two weeks of their life.

That is why family engagement is not an ancillary service. Families need to understand the stakes, know how to respond to the “come get me” call, understand why step-down care matters, and be prepared to support the treatment plan when their loved one is most tempted to abandon it. A family that has been prepared for that call before it comes is one of the most effective overdose-prevention tools a program has — and one of the few that keeps working after discharge.

What operators can do this month

• Treat AMA rate, completion rate, and 7/14-day step-down connection as overdose-prevention metrics, and report them that way to your board

• Prepare every family for the “come get me” call at intake, not after it happens

• Build a structured 14-day post-discharge contact protocol for every residential discharge, with the family as a participant

• Make sure every discharged patient and family has naloxone and knows the first-two-weeks risk in plain language

• Track who you could not reach after discharge, and treat that number as a risk signal rather than a data gap

Reducing overdose requires more than responding to the moment of crisis. It means keeping people in treatment, helping them transition to the next level of care, and strengthening the recovery environment they return to. Families influence every one of those moments. The next overdose may be prevented long before it happens, by helping someone enter treatment, stay in treatment, and remain connected to recovery when they leave.

Frequently Asked Questions

Are overdose deaths in the United States going down?

Yes. Provisional CDC data estimate 69,973 drug overdose deaths in 2025, down nearly 14% from an estimated 81,313 in 2024. It is the third consecutive annual decline. The 2025 figures are provisional and may change as more data are reported.

When is the highest overdose risk after addiction treatment?

The first 14 days after treatment ends. A New York City cohort study of 51,171 treatment terminations found that more than 40% of overdose deaths within 90 days occurred in the first two weeks, with an overdose death rate of 71.6 per 1,000 person-years in that window. Patients leaving residential treatment were at higher risk than those leaving detox, opioid treatment programs, or outpatient care.

Why is AMA discharge an overdose prevention issue?

Leaving treatment early moves a patient directly into the highest-risk post-treatment period without a planned transition to the next level of care. Programs that reduce against-medical-advice discharge and improve step-down connection within 7 or 14 days are reducing exposure to that window, which makes retention and completion metrics overdose-prevention metrics.

How can families unintentionally increase overdose risk?

When a patient calls and asks to be picked up from treatment, families often agree out of fear or a desire to relieve their loved one’s distress. Supporting an early discharge can raise the risk of relapse and overdose. Families who are prepared for that call before it comes, and who understand why step-down care matters, are far better able to support the treatment plan.

What does SAMHSA measure for transitions after residential treatment?

SAMHSA quality measures track whether a person leaving inpatient or residential substance use treatment connects with another treatment service within 7 days and within 14 days of discharge, reflecting the narrow window in which continuity of care matters most.

What should treatment programs do for International Overdose Awareness Day?

Beyond naloxone distribution and awareness, programs can reframe their retention and transition metrics as overdose prevention, prepare every family for the “come get me” call at intake, build a structured 14-day post-discharge contact protocol that includes the family, and track patients who cannot be reached after discharge as a risk signal.

Sources

• CDC National Center for Health Statistics (May 2026). U.S. Overdose Deaths Decrease for Third Consecutive Year in 2025 (provisional data)

• CDC, State Unintentional Drug Overdose Reporting System (SUDORS), 2024 data on potential opportunities for intervention

• Journal of Urban Health (2024). Drug Overdose Death Following Substance Use Disorder Treatment Termination in New York City: A Retrospective Longitudinal Cohort Study

• New York State Office of Addiction Services and Supports (June 2024). Addiction Data Bulletin 2024-03

• SAMHSA, Behavioral Health Quality Measures: Follow-up after discharge from residential/inpatient SUD treatment (7- and 14-day)

• SAMHSA, Treatment Improvement Protocol (TIP) 39: Substance Use Disorder Treatment and Family Therapy (updated 2020)

• Agency for Healthcare Research and Quality, Patient Safety Network: Discharge Against Medical Advice

• International Overdose Awareness Day, August 31